Addex Initiates New Study in Collaboration with US National Institute of Drug Abuse with ADX88178 in Non-Human Primate Model of Cocaine Addiction

Addex Therapeutics Reports First Half 2016 Operating Highlights and Financial Results

Addex Collaborators Published New Data Supporting the Role of Negative Allosteric Modulators of Follicle Stimulating Hormone and Luteinizing Hormone Receptors in Reproductive Health

Addex ADX71441 Demonstrates Positive Results in Highly Translational Preclinical Model of Spasticity.

LifeSci Capital Issues Equity Research Report on Addex Therapeutics

Addex Shareholders Approved all Board Proposals at 2016 Annual General Meeting

Addex mGluR4 and mGluR7 Programs Demonstrate Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases

Addex ADX71441 Demonstrates Positive Results in Non-Human Primate Model of Cocaine Addiction

Van Leeuwenhoeck Issues Research Note on Addex Therapeutics

Addex Annual General Meeting Scheduled for 23 June 2016